menu
    • menu

    Company profile for Synnovation Therapeutics

    NEW Drugs in Dev: 2
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Synnovation Therapeutics is a precision medicine firm focused on crafting small molecule therapies meticulously designed to deliver superior pharmacology against extensively validated disease targets. Our commitment revolves around the exploration and advancement of top-tier therapeutics aimed at enhancing the quality of life for individuals coping with cancer. With an in-depth understanding of cancer biology and a team of wor...
    Synnovation Therapeutics is a precision medicine firm focused on crafting small molecule therapies meticulously designed to deliver superior pharmacology against extensively validated disease targets. Our commitment revolves around the exploration and advancement of top-tier therapeutics aimed at enhancing the quality of life for individuals coping with cancer. With an in-depth understanding of cancer biology and a team of world-class medicinal chemists, we are actively constructing a varied pipeline of groundbreaking small molecule targeted therapies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Synnovation TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Wilmington, DE 19803
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.synnovationtx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/synnovationtx/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Synnovation To Present SNV1521 Phase 1 Data At ESMO 2025
    Synnovation To Present SNV1521 Phase 1 Data At ESMO 2025

    14 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251014327937/en/Synnovation-to-Present-SNV1521-PARP1-Phase-1-Study-Results-at-the-European-Medical-Oncology-ESMO-Congress-2025-and-Announces-Clinical-Collaboration-with-DualityBio-to-Evaluate-the-Combination-of-SNV1521-with-Dualitys-HER3-ADC-DB-1310

    BUSINESSWIRE
    14 Oct 2025
    Share Share
    Synnovation Starts Ph 1 SNV4818 Trial For Tumors With PI3K? Inhibitor
    Synnovation Starts Ph 1 SNV4818 Trial For Tumors With PI3K? Inhibitor

    24 Feb 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250224271326/en

    BUSINESSWIRE
    24 Feb 2025
    Share Share
    Synnovation Announces First Patient Dosed in Phase I Trial with SNV1521
    Synnovation Announces First Patient Dosed in Phase I Trial with SNV1521

    11 Mar 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240311306666/en

    BUSINESSWIRE
    11 Mar 2024
    Share Share
    Synnovation Launches with $102M to Advance Pipeline of Precision Therapies
    Synnovation Launches with $102M to Advance Pipeline of Precision Therapies

    24 Jan 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240124063504/en

    BUSINESSWIRE
    24 Jan 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search